Mark D. Rolsma

517 total citations
10 papers, 407 citations indexed

About

Mark D. Rolsma is a scholar working on Infectious Diseases, Small Animals and Endocrinology. According to data from OpenAlex, Mark D. Rolsma has authored 10 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Small Animals and 3 papers in Endocrinology. Recurrent topics in Mark D. Rolsma's work include Viral gastroenteritis research and epidemiology (4 papers), Escherichia coli research studies (3 papers) and Veterinary medicine and infectious diseases (2 papers). Mark D. Rolsma is often cited by papers focused on Viral gastroenteritis research and epidemiology (4 papers), Escherichia coli research studies (3 papers) and Veterinary medicine and infectious diseases (2 papers). Mark D. Rolsma collaborates with scholars based in United States. Mark D. Rolsma's co-authors include Howard B. Gelberg, Mark S. Kuhlenschmidt, Theresa B. Kuhlenschmidt, Maria Toivio‐Kinnucan, M.A Cheadle, David S. Lindsay, M. A. Williams, Jennifer A. Spencer, Byron L. Blagburn and Christine C. Dykstra and has published in prestigious journals such as Journal of Virology, Infection and Immunity and Acta Neuropathologica.

In The Last Decade

Mark D. Rolsma

10 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Rolsma United States 7 153 103 80 77 76 10 407
Oyebola O. Oyesola United States 12 75 0.5× 92 0.9× 58 0.7× 28 0.4× 54 0.7× 22 356
Mehmet Halıgür Türkiye 12 77 0.5× 58 0.6× 51 0.6× 75 1.0× 54 0.7× 53 391
Michael D. Elftman United States 10 167 1.1× 20 0.2× 69 0.9× 203 2.6× 136 1.8× 13 530
Maria V. McCrossan United Kingdom 13 99 0.6× 126 1.2× 19 0.2× 128 1.7× 131 1.7× 18 522
Corinna Weber Germany 12 42 0.3× 28 0.3× 38 0.5× 37 0.5× 48 0.6× 45 366
Carlos Lopez Mexico 12 76 0.5× 42 0.4× 108 1.4× 479 6.2× 67 0.9× 19 726
R. Alonso Spain 9 50 0.3× 112 1.1× 33 0.4× 47 0.6× 71 0.9× 20 359
M K Davidson United States 13 28 0.2× 55 0.5× 23 0.3× 153 2.0× 134 1.8× 24 519
Amanda Gallagher United Kingdom 5 49 0.3× 125 1.2× 15 0.2× 21 0.3× 106 1.4× 6 361
Yan Fu China 12 38 0.2× 87 0.8× 45 0.6× 65 0.8× 154 2.0× 28 567

Countries citing papers authored by Mark D. Rolsma

Since Specialization
Citations

This map shows the geographic impact of Mark D. Rolsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Rolsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Rolsma more than expected).

Fields of papers citing papers by Mark D. Rolsma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Rolsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Rolsma. The network helps show where Mark D. Rolsma may publish in the future.

Co-authorship network of co-authors of Mark D. Rolsma

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Rolsma. A scholar is included among the top collaborators of Mark D. Rolsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Rolsma. Mark D. Rolsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Obert, Leslie, et al.. (2007). An Immunohistochemical Approach to Differentiate Hepatic Lipidosis from Hepatic Phospholipidosis in Rats. Toxicologic Pathology. 35(5). 728–734. 47 indexed citations
2.
Martin, Douglas R., Nancy R. Cox, Nancy E. Morrison, et al.. (2005). Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. Acta Neuropathologica. 110(5). 443–450. 34 indexed citations
3.
Schumacher, John, et al.. (2000). Surgical and Medical Treatment of an Arabian Filly with Proliferative Enteropathy Caused by Lawsonia intracellularis. Journal of Veterinary Internal Medicine. 14(6). 630–632. 40 indexed citations
4.
Schumacher, John N., James Schumacher, Mark D. Rolsma, Kenny V. Brock, & Connie J. Gebhart. (2000). Surgical and Medical Treatment of an Arabian Filly with Proliferative Enteropathy Caused by Lawsonia intrecellularis. Journal of Veterinary Internal Medicine. 14(6). 630–630. 1 indexed citations
5.
Cheadle, M.A, David S. Lindsay, Stacey L Rowe, et al.. (1999). Prevalence of antibodies to Neospora Caninum in dogs. International Journal for Parasitology. 29(10). 1537–1543. 85 indexed citations
6.
Rolsma, Mark D., et al.. (1998). Rabies in a llama. Veterinary medicine. 93(10). 934–936. 3 indexed citations
7.
Rolsma, Mark D., Theresa B. Kuhlenschmidt, Howard B. Gelberg, & Mark S. Kuhlenschmidt. (1998). Structure and Function of a Ganglioside Receptor for Porcine Rotavirus. Journal of Virology. 72(11). 9079–9091. 121 indexed citations
8.
Kuhlenschmidt, Mark S., Mark D. Rolsma, Theresa B. Kuhlenschmidt, & Howard B. Gelberg. (1997). Characterization of a Porcine Enterocyte Receptor for Group a Rotavirus. Advances in experimental medicine and biology. 412. 135–143. 5 indexed citations
9.
Rolsma, Mark D., Howard B. Gelberg, & Mark S. Kuhlenschmidt. (1994). Assay for evaluation of rotavirus-cell interactions: identification of an enterocyte ganglioside fraction that mediates group A porcine rotavirus recognition. Journal of Virology. 68(1). 258–268. 59 indexed citations
10.
Kuhlenschmidt, Mark S., et al.. (1994). An intestinal xenograft model for Cryptosporidium parvum infection. Infection and Immunity. 62(1). 329–331. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026